Protective effect of T cell receptor-heat shock protein 70 DNA vaccines on collagen-induced arthritis
J Xiao,W Wang,ZG Li,PL Ge,WX He,LY Wang,WM Zhao
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.45.027
2007-01-01
Abstract:Aim: To purify recombinant DNA vaccines encoding T cell receptor (TCR) Vβ5.2/8.2 and a conserved tubercule bacillus heat-shock protein (HSP) 70 sequence, and evaluate the protective effects of them on collagen-induced arthritis (CIA). Methods: The experiment was conducted in the Department of Immunology, Capital Medical University from July 2006 to February 2007. 1 Thirty-six Lewis rats were randomly divided into 6 groups (n=6): normal control group, CIA control group, empty plasmid group, pTARGET-TCR Vβ5.2-HSP70 group, pTARGET-TCR Vβ8.2-HSP70 and combined group of pTARGET-TCR Vβ5.2-HSP70 and pTARGET-TCR Vβ8.2-HSP70. 2 Recombinant DNA vaccines pTARGET-TCR Vβ5.2-HSP70, pTARGET-TCR Vβ8.2-HSP70 and empty plasmid pTARGET were prepared and purified abundantly, then the protective effects of recombinant DNA vaccines on CIA rats were observed, including arthritis index evaluation, interferon-gamma (IFN-γ) and interleukin-4 (IL-4) production by spleen cells with Eli-spot technique, the level of anti-type II collagen antibody in serum assayed by enzyme-linked immunosorbent assay (ELISA), and articular pathologic changes in hind limbs under light microscope. Results: All 36 rats were involved in the result analysis. pTARGET-TCR Vβ5.2-HSP70 and pTARGET-TCR Vβ8.2-HSP70 recombinant DNA vaccines displayed good protective effects on CIA rats. Compared with CIA control group, they could alleviate arthritis index (P < 0.05), decrease the levels of IFN-γ production (P < 0.05) and anti-type II collagen antibody in serum (P < 0.01), and increase the level of IL-4 production (P < 0.05). In addition, the pathologic change was lessened. Moreover, the injection of the combination of two vaccines showed better protective effects on CIA rats than each of them individually. Conclusion: Recombinant DNA vaccines pTARGET-TCR Vβ5.2-HSP70 and pTARGET-TCR Vβ8.2-HSP70 can alleviate the arthritis symptoms and pathological changes of CIA rats significantly, and the combination of the two vaccines would get better protective effects.